Stocks
Infinity Pharmaceuticals, Inc.INFI
NASDAQHealthcareBiotechnology$0.01-52.38%
A biotechnology company focused on developing small‑molecule therapies for cancer, particularly targeting the PI3K signaling pathway involved in hematologic malignancies. Its lead programs have included treatments for blood cancers such as leukemia and lymphoma, with development efforts centered on ...
Market Cap: $726,08952W Range: $0.01 – $1.30
Congressional Interest in Infinity Pharmaceuticals, Inc. (INFI)
2 members of Congress have disclosed 2 trades in Infinity Pharmaceuticals, Inc. (INFI), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading INFI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-12 | Roger W. Marshall | buy | $1K – $15K |
| 2016-10-14 | JAMES B. RENACCI | sell | $1K – $15K |